In June 2026, Grasim Industries inaugurated Phase 1 of a landmark CPVC resin manufacturing facility at Vilayat, Gujarat. But what makes this 50,000 metric tonne plant remarkable isn't just its capacity—it's the revolutionary partnership structure behind it.
The deal structure is unprecedented in Indian chemicals.
Grasim provides land, materials, utilities, and manages plant operations for commercial considerations. The products sell under Lubrizol's established TempRite brand, with specific business model terms protected under confidentiality agreements. InvestorPresentations +1
For Grasim, this means zero capital expenditure on its balance sheet while participating in a high-growth market segment. The company is protected from CPVC price volatility while still benefiting from demand growth. It's asymmetric upside—market exposure without capital risk. Transcripts
The Vilayat facility leverages Lubrizol's position as the inventor and largest manufacturer of CPVC resin worldwide. This technology integration delivers immediate production efficiency advantages that would take years to develop independently. The plant utilizes Lubrizol's proprietary CPVC resin manufacturing technology, coupled with Grasim's manufacturing capabilities, to enable access to locally manufactured CPVC material.
The captive chlorine integration at Vilayat provides a crucial competitive edge. Grasim's chlorine integration is expected to reach approximately 70% upon completion and commissioning of ongoing projects including the CPVC facility. This integration eliminates exposure to chlorine market volatility—during Q1 FY26, chlorine traded at negative ₹6,000-6,500 per ton. By consuming chlorine captive, Grasim avoids these negative realizations while improving overall margins. AnnualReports +2
The quality implications are equally significant. Products manufactured under Lubrizol's TempRite brand must meet stringent global quality standards, creating inherent quality discipline in manufacturing operations. This isn't about competing on price—it's about premium positioning in performance-critical applications where product reliability matters more than cost. Transcripts
The timing couldn't be better. India has been the largest CPVC importer globally for several years, with monthly imports ranging between 8-15 kilo tons (96-180 KTPA annually) during 2022-2023. This complete import dependency created a massive supply gap that domestic manufacturers are now addressing.
The market fundamentals are robust: the global CPVC market was valued at USD 2.4 billion in 2025 and is projected to reach USD 5.4 billion by 2035, growing at a CAGR of 8.4%. The Asia Pacific region is identified as the fastest-growing market, driven by rapid urbanization and infrastructure development. InvestorPresentations
The application breakdown reveals why demand is surging. Plumbing and water distribution dominate with 49% of total sales volume in 2025. Fire protection systems are growing rapidly at 10.1% CAGR—the fastest-growing segment. Industrial piping and HVAC applications are expanding as CPVC replaces traditional metal systems due to corrosion resistance and cost advantages.
Government protection measures support domestic production.
This regulatory environment, combined with the "Make in India" initiative, creates favorable conditions for Grasim's market penetration.
Grasim's phased approach to the 100 KTPA total capacity demonstrates sophisticated capital allocation thinking. Phase 1 (50 KTPA) allows market demand validation before committing to Phase 2 expansion. It provides earlier revenue generation while reducing initial capital requirements—though in this case, Lubrizol bears the capital burden anyway.
The phased approach delivers several strategic advantages. Faster Phase 1 commissioning enables first-mover advantages in India's CPVC import substitution opportunity. Operational experience from Phase 1 optimizes Phase 2 design and execution. Market demand can be validated before Phase 2 commitment, reducing investment risk.
The Vilayat complex houses complementary projects that strengthen the value proposition. Alongside the CPVC plant, Grasim is commissioning an Epichlorohydrin (ECH) plant (50 KTPA) at the same location. Both projects are expected to contribute meaningfully to operating profits from Q1 FY27. InvestorPresentations +1
The CPVC facility plays a pivotal role in Grasim's chlorine integration strategy, which is fundamental to the chemicals business's profitability. The company aims to increase chlorine integration from current levels of approximately 63% to 70% post-commissioning of ongoing projects. Transcripts +1
This integration directly improves overall business economics by better utilizing chlorine by-products from chlor-alkali operations. The chemicals segment demonstrated improved profitability with EBITDA growing 3% YoY to ₹304 crore in Q4 FY26, driven by higher sales volumes of caustic and chlorine derivatives. Transcripts +1
The revenue mix transformation is equally strategic. Specialty chemicals now contribute 27% and chlorine derivatives 22% of chemical revenues. This represents a deliberate shift away from over-reliance on basic chlor-alkali products (51% of revenues) toward more profitable specialty and derivative segments. Transcripts +1
The existing land parcel at Vilayat is currently "fully utilized," representing a significant constraint for immediate expansion. However, Grasim has approved acquisition of a large land parcel at Vilayat specifically for value-added product expansion in the chemical business, with approximately Rs. 250-260 crore allocated in FY23. Transcripts +1
Within the existing Vilayat site, space is available for further doubling ECH capacity, with environmental clearances already in place. This expansion would create surplus ECH capacity (10-15 kilotons) for trading, beyond meeting internal requirements. The strategy includes small salt fields and complete value chain integration. Transcripts
The decision for Phase 2 CPVC expansion will be influenced by several demand triggers. Sustained Phase 1 capacity utilization above 85% for 6-12 months would signal market readiness. Order book strength indicating demand exceeding current capacity, successful penetration of target market segments, and competitive landscape movements—particularly Epigral expanding to 150 KTPA by 2026 and Reliance Industries planning 1,500 KTPA combined PVC/CPVC capacity by 2027—will all factor into the timing decision.
Supporting potential capacity scaling requires developing sophisticated operational capabilities. The company acknowledges that "start-up times of these plants are long and complicated" with inherent "safety risks". This necessitates advanced process safety management systems and comprehensive risk assessment protocols. Transcripts
Grasim has demonstrated capability to achieve "Integrated Management System" Certificate encompassing ISO 9001, 14001, and 45001 certifications across multiple plants in less than 18 months of full-scale operation. Similar comprehensive quality frameworks will be essential for the Lubrizol partnership. Transcripts
The company's experience with "IoT-driven automation, helping standardization and consistency of quality" provides a foundation for developing standardized quality processes that can be scaled across expanded capacity. Cross-functional expertise that can effectively collaborate with Lubrizol's technical teams while maintaining Grasim's operational standards will be critical. Transcripts
The CPVC manufacturing capability enhances Grasim's competitive positioning within Aditya Birla Group's Global Chemicals portfolio through multiple dimensions. It aligns with the group's focus on "specialty products through innovation" and maintaining "leadership position in all our businesses". InvestorPresentations +1
The partnership model provides strategic advantages that direct competition cannot match. Access to world-class CPVC technology from the global leader, established TempRite brand recognition, immediate market access through Lubrizol's distribution networks, and price volatility protection while benefiting from demand growth create sustainable competitive barriers. Transcripts
The Vilayat facility expansion represents a critical component of Grasim's broader chemicals strategy, enabling transformation from a basic chemical manufacturer to a more diversified, integrated player with presence across the value chain and multiple high-growth end markets. It's not just about CPVC—it's about building a platform for specialty chemicals leadership.
As India's infrastructure boom accelerates and the government pushes for import substitution, Grasim's zero-capex partnership with Lubrizol positions the company to capture significant value while maintaining financial flexibility. The Phase 1 inauguration is just the beginning—the real story will unfold as Phase 2 decisions are made and this strategic partnership demonstrates its full potential in India's evolving chemicals landscape.
